Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure

Erin R. Ewald, Gary S Wand, Fayaz Seifuddin, Xiaoju Yang, Kellie Tamashiro, James Bennett Potash, Peter P Zandi, Richard Lee

Research output: Contribution to journalArticle

Abstract

Background: Epigenetic studies that utilize peripheral tissues to identify molecular substrates of neuropsychiatric disorders rely on the assumption that disease-relevant, cellular alterations that occur in the brain are mirrored and detectable in peripheral tissues such as blood. We sought to test this assumption by using a mouse model of Cushing's disease and asking whether epigenetic changes induced by glucocorticoids can be correlated between these tissue types. Methods: Mice were treated with different doses of glucocorticoids in their drinking water for four weeks to assess gene expression and DNA methylation (DNAm) changes in the stress response gene Fkbp5. Results: Significant linear relationships were observed between DNAm and four-week mean plasma corticosterone levels for both blood (R2=0.68, P=7.1×10-10) and brain (R2=0.33, P=0.001). Further, degree of methylation change in blood correlated significantly with both methylation (R2=0.49, P=2.7×10-5) and expression (R2=0.43, P=3.5×10-5) changes in hippocampus, with the notable observation that methylation changes occurred at different intronic regions between blood and brain tissues. Conclusion: Although our findings are limited to several intronic CpGs in a single gene, our results demonstrate that DNA from blood can be used to assess dynamic, glucocorticoid-induced changes occurring in the brain. However, for such correlation analyses to be effective, tissue-specific locations of these epigenetic changes may need to be considered when investigating brain-relevant changes in peripheral tissues.

Original languageEnglish (US)
Pages (from-to)112-122
Number of pages11
JournalPsychoneuroendocrinology
Volume44
DOIs
StatePublished - 2014

Fingerprint

DNA Methylation
Glucocorticoids
Brain
Epigenomics
Methylation
Pituitary ACTH Hypersecretion
Corticosterone
Drinking Water
Genes
Hippocampus
Gene Expression
DNA

Keywords

  • And glucocorticoids
  • Biomarker
  • Blood-brain correlation
  • DNA methylation
  • Epigenetics
  • Fkbp5

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Medicine(all)

Cite this

Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure. / Ewald, Erin R.; Wand, Gary S; Seifuddin, Fayaz; Yang, Xiaoju; Tamashiro, Kellie; Potash, James Bennett; Zandi, Peter P; Lee, Richard.

In: Psychoneuroendocrinology, Vol. 44, 2014, p. 112-122.

Research output: Contribution to journalArticle

@article{490dcf08857d4e8a8d686e9d90ca3b70,
title = "Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure",
abstract = "Background: Epigenetic studies that utilize peripheral tissues to identify molecular substrates of neuropsychiatric disorders rely on the assumption that disease-relevant, cellular alterations that occur in the brain are mirrored and detectable in peripheral tissues such as blood. We sought to test this assumption by using a mouse model of Cushing's disease and asking whether epigenetic changes induced by glucocorticoids can be correlated between these tissue types. Methods: Mice were treated with different doses of glucocorticoids in their drinking water for four weeks to assess gene expression and DNA methylation (DNAm) changes in the stress response gene Fkbp5. Results: Significant linear relationships were observed between DNAm and four-week mean plasma corticosterone levels for both blood (R2=0.68, P=7.1×10-10) and brain (R2=0.33, P=0.001). Further, degree of methylation change in blood correlated significantly with both methylation (R2=0.49, P=2.7×10-5) and expression (R2=0.43, P=3.5×10-5) changes in hippocampus, with the notable observation that methylation changes occurred at different intronic regions between blood and brain tissues. Conclusion: Although our findings are limited to several intronic CpGs in a single gene, our results demonstrate that DNA from blood can be used to assess dynamic, glucocorticoid-induced changes occurring in the brain. However, for such correlation analyses to be effective, tissue-specific locations of these epigenetic changes may need to be considered when investigating brain-relevant changes in peripheral tissues.",
keywords = "And glucocorticoids, Biomarker, Blood-brain correlation, DNA methylation, Epigenetics, Fkbp5",
author = "Ewald, {Erin R.} and Wand, {Gary S} and Fayaz Seifuddin and Xiaoju Yang and Kellie Tamashiro and Potash, {James Bennett} and Zandi, {Peter P} and Richard Lee",
year = "2014",
doi = "10.1016/j.psyneuen.2014.03.003",
language = "English (US)",
volume = "44",
pages = "112--122",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure

AU - Ewald, Erin R.

AU - Wand, Gary S

AU - Seifuddin, Fayaz

AU - Yang, Xiaoju

AU - Tamashiro, Kellie

AU - Potash, James Bennett

AU - Zandi, Peter P

AU - Lee, Richard

PY - 2014

Y1 - 2014

N2 - Background: Epigenetic studies that utilize peripheral tissues to identify molecular substrates of neuropsychiatric disorders rely on the assumption that disease-relevant, cellular alterations that occur in the brain are mirrored and detectable in peripheral tissues such as blood. We sought to test this assumption by using a mouse model of Cushing's disease and asking whether epigenetic changes induced by glucocorticoids can be correlated between these tissue types. Methods: Mice were treated with different doses of glucocorticoids in their drinking water for four weeks to assess gene expression and DNA methylation (DNAm) changes in the stress response gene Fkbp5. Results: Significant linear relationships were observed between DNAm and four-week mean plasma corticosterone levels for both blood (R2=0.68, P=7.1×10-10) and brain (R2=0.33, P=0.001). Further, degree of methylation change in blood correlated significantly with both methylation (R2=0.49, P=2.7×10-5) and expression (R2=0.43, P=3.5×10-5) changes in hippocampus, with the notable observation that methylation changes occurred at different intronic regions between blood and brain tissues. Conclusion: Although our findings are limited to several intronic CpGs in a single gene, our results demonstrate that DNA from blood can be used to assess dynamic, glucocorticoid-induced changes occurring in the brain. However, for such correlation analyses to be effective, tissue-specific locations of these epigenetic changes may need to be considered when investigating brain-relevant changes in peripheral tissues.

AB - Background: Epigenetic studies that utilize peripheral tissues to identify molecular substrates of neuropsychiatric disorders rely on the assumption that disease-relevant, cellular alterations that occur in the brain are mirrored and detectable in peripheral tissues such as blood. We sought to test this assumption by using a mouse model of Cushing's disease and asking whether epigenetic changes induced by glucocorticoids can be correlated between these tissue types. Methods: Mice were treated with different doses of glucocorticoids in their drinking water for four weeks to assess gene expression and DNA methylation (DNAm) changes in the stress response gene Fkbp5. Results: Significant linear relationships were observed between DNAm and four-week mean plasma corticosterone levels for both blood (R2=0.68, P=7.1×10-10) and brain (R2=0.33, P=0.001). Further, degree of methylation change in blood correlated significantly with both methylation (R2=0.49, P=2.7×10-5) and expression (R2=0.43, P=3.5×10-5) changes in hippocampus, with the notable observation that methylation changes occurred at different intronic regions between blood and brain tissues. Conclusion: Although our findings are limited to several intronic CpGs in a single gene, our results demonstrate that DNA from blood can be used to assess dynamic, glucocorticoid-induced changes occurring in the brain. However, for such correlation analyses to be effective, tissue-specific locations of these epigenetic changes may need to be considered when investigating brain-relevant changes in peripheral tissues.

KW - And glucocorticoids

KW - Biomarker

KW - Blood-brain correlation

KW - DNA methylation

KW - Epigenetics

KW - Fkbp5

UR - http://www.scopus.com/inward/record.url?scp=84899534761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899534761&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2014.03.003

DO - 10.1016/j.psyneuen.2014.03.003

M3 - Article

VL - 44

SP - 112

EP - 122

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

ER -